Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aeterna Zentaris Inc

+ Add to Watchlist

AEZS:US

0.6410 USD 0.0310 5.08%

As of 20:10:00 ET on 04/17/2015.

Company Profile for Aeterna Zentaris Inc (AEZS)

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval.

Contact Information

Aeterna Zentaris Inc

1405 du Parc-Technologique Blv
Quebec, QC
Canada
Phone: 1-418-652-8525
Fax: 1-418-948-9191

Key Executives for Aeterna Zentaris Inc (AEZS)

David A DoddPresident/CEODennis TurpinSenior VP/CFO
Philip A TheodoreSenior VP/CAO/Secy/Gen CnslJude DingesSenior VP/Chief Commercial Ofcr
Richard SachseSenior VP/Chief Scientific OfcrGinette Beaudet VallieresInvestor Relations Coordinator

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil